694
INDEX
Climbing fibers, 255
Clinical uses of EEG, 232–233
Clonal selection, 71
Clonic phase, 233
Clonus, 163
Closing volume, 600
Clotting mechanism, 531–533
Clozapine, 140
CMR 1.
See
Cold- and menthol-sensitive
receptor 1
CNG.
See
Cyclic nucleotidegated
CNP.
See
C-type natriuretic peptide
CNTF.
See
Ciliary neurotrophic factor
CO
2
narcosis, 630
CoA.
See
Coenzyme A
Coats, 45
Cochlea, 205
Cochlear division.
See
Auditory division
Coding, sensory, 152–153
duration, 153
intensity, 153
location, 152–153
modality, 152
Codons, 17
Coenzyme A, 8
Cogwheel rigidity, 253
COHb.
See
Carboxyhemoglobin
Cold- and menthol-sensitive receptor 1, 168
Cold receptors, 168
Colipase, 457
Collapsing pulse, 512
Collateral ganglia.
See
Prevertebral ganglia
Collecting ducts, 641
Colloid, 302
Colon, 475–478
defecation, 476–478
motility of colon, 475–476
short-chain fatty acids in, 458
small intestine, 476
transit time, 476
Colony-stimulating factors, 65
Color agnosia, 155
Color blindness, 196
Color vision, 195–197
characteristics of color, 195–196
neural mechanisms, 197
retinal mechanisms, 196–197
Coma, 324
Comedones, 418
Common metabolic pool, 18
Communicating hydrocephalus, 571
Compensatory pause, 500
Complement system, 69
Complementary color, 195
Complete androgen resistance syndrome, 398
Complete heart block, 497
Complete tetanus, 101
Complex cells, 194
Compliance of lungs, chest wall, 595–596
COMT.
See
Catechol-
O
-methyltransferase
Concentration gradient, 5, 7
Concentration of solutes, units for measuring, 2
equivalents, 2
moles, 2
Concordance rate, 334
Conditionally essential, 15
Conditioned reflex, 292
Conditioned stimulus, 292
Conduction, 284
Conduction aphasia, 297
Conductive deafness, 213
Cone pigments, 192
Cones, 182
Confabulation, 293
Congenital adrenal hyperplasia, 346
Congenital lipodystrophy, 334
Congenital lipoid adrenal hyperplasia, 346
Conn syndrome, 359
Connecting peptides, 318
Consensual light reflex, 189
Constitutive pathway, 43
Contraception, 422
Contractile responses, 96–102, 107–108
fiber types, 102
molecular basis of contraction, 97–100
muscle twitch, 97
relation between muscle length, tension, 102
summation of contractions, 101–102
types of contraction, 100–101
Contraction
molecular basis, 97–100, 110–111
tetanic (
See
Tetanus)
Contrecoup injury, 572
Control of ovarian function, 420–422
contraception, 422
control of cycle, 421
feedback effects, 421
hypothalamic components, 420–421
reflex ovulation, 421–422
Convection, 284
Convergence movements, 199
Convergence-projection theory, 170
Convulsive, 233
Cornea, 181
Coronary chemoreflex, 632
Coronary circulation, 577–580
anatomic considerations, 577–578
chemical factors, 579–580
neural factors, 580
pressure gradients, 578–579
variations in coronary flow, 579
Coronary flow, variations in, 579
Corpus albicans, 412
Corpus hemorrhagicum, 412
Corpus luteum, 412
Corpus luteum of pregnancy, 424
Correlation between muscle fiber length, tension,
109
Corresponding points, 198
Corrigan pulse, 512
Cortex, 193–195, 394
cortical areas concerned with vision, 195
pathways to cortex, 193–194
primary visual cortex, 194–195
Cortical bone, 371
Cortical dipoles, 232
Cortical nephrons, 640
Cortical organization, 230–231
Cortical plasticity, 176
Corticobulbar tract, 242–243
Corticospinal tract, 242–243
Corticosteroid-binding globulin, 346
Corticosterone, 338, 343
Corticostriate pathway, 250
Corticotropin, 279
Corticotropin-releasing hormone, 280
Cortisol, 343
Cotransporter, 453
Coughing, 632
Countercurrent exchange, 285
Countercurrent exchangers, 654
Countercurrent multipliers, 654
Coupling, reaction, 304
Coupling ratio, 47COX1, 28
COX2, 28
Craniosacral division, 265
CREB. See cAMP-responsive element-binding
protein
Cretins, 387
CRH. See Corticotropin-releasing hormone
CRH-binding protein, 282
Crista ampullaris, 206
Cristae, 34
Critical fusion frequency, 197
Critical micelle concentration, 440
Critical velocity, 540, 545
Crossed extensor response, 164
Cryptorchidism, 410
Crystalline lens, 181
CSFs. See Colony-stimulating factors
Cuneate nuclei, 173
Cupula, 206
Cushing disease, 351
Cushing reflex, 562
Cushing syndrome, 350–351, 359
Cutaneous circulation, 580–581
reactive hyperemia, 581
triple response, 580–581
white reaction, 580
Cutaneous receptors, generation of impulses in,
151–152
generator potentials, 151
Pacinian corpuscles, 151
source of generator potential, 151–152
CV. See Closing volume
Cyanmethemoglobin, 621
Cyanotic congenital heart disease, 620
Cyclic AMP, 56, 327
Cyclic guanosine monophosphate, 57, 112
Cyclic nucleotidegated, 223
Cyclopentanoperhydrophenanthrene nucleus,
342
Cyclosporine, 75
CYP17, 345
CYP19. See Aromatase
CYP11A1, 344
CYP11B1, 345
CYP11B2, 345
CYP21A2, 345
Cystinuria, 456
Cystometrogram, 661
Cystometry, 661
Cytokines, 67–69
Cytopempsis, 49
Cytoplasmic dyneins, 37
Cytoskeleton, 35–36
Cytotoxic T cells, 70
Cytotrophoblast, 423D
DAG. See
Diacylglycerol
Dark adaptation, 197
Dead space, 599–600
Deafness, 213
nonsyndromic, 214
syndromic, 214
Decerebellate rigidity, 247
Decerebrate rigidity, 247
Decerebration, 247
Decibel scale, 209
Declarative memory, 290
Decomposition of movement, 258
Decorticate rigidity, 247
Decortication, 247
Decubitus ulcers, 250